UA113237U - PHARMACEUTICAL COMBINATION OF ACECLOPHENAC AND SODIUM OR ANALYTING COMPONENT - Google Patents

PHARMACEUTICAL COMBINATION OF ACECLOPHENAC AND SODIUM OR ANALYTING COMPONENT

Info

Publication number
UA113237U
UA113237U UAU201605817U UAU201605817U UA113237U UA 113237 U UA113237 U UA 113237U UA U201605817 U UAU201605817 U UA U201605817U UA U201605817 U UAU201605817 U UA U201605817U UA 113237 U UA113237 U UA 113237U
Authority
UA
Ukraine
Prior art keywords
component
analyting
aceclophenac
sodium
pharmaceutical combination
Prior art date
Application number
UAU201605817U
Other languages
Ukrainian (uk)
Inventor
Антон Миколайович Сікорський
Original Assignee
Антон Миколайович Сікорський
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Антон Миколайович Сікорський filed Critical Антон Миколайович Сікорський
Priority to UAU201605817U priority Critical patent/UA113237U/en
Publication of UA113237U publication Critical patent/UA113237U/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Фармацевтична композиція для перорального споживання, яка є комбінацією щонайменше двох активних компонентів в їхніх ефективних кількостях, в тому числі у вигляді фармацевтично прийнятних солей, сольватів, естерів, оптичних ізомерів та прекурсорів, які вивільняються негайно, при цьому один з компонентів проявляє снодійний та/або заспокійливий ефект, а другий - знеболюючий ефект. Як знеболювальний компонент - є ацеклофенак.Oral pharmaceutical composition which is a combination of at least two active ingredients in their effective amounts, including in the form of pharmaceutically acceptable salts, solvates, esters, optical isomers and precursors, which are released immediately, with one of the components exhibiting sleeping pills and / or the soothing effect and the second the analgesic effect. As an analgesic component - is aceclofenac.

UAU201605817U 2016-05-30 2016-05-30 PHARMACEUTICAL COMBINATION OF ACECLOPHENAC AND SODIUM OR ANALYTING COMPONENT UA113237U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201605817U UA113237U (en) 2016-05-30 2016-05-30 PHARMACEUTICAL COMBINATION OF ACECLOPHENAC AND SODIUM OR ANALYTING COMPONENT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201605817U UA113237U (en) 2016-05-30 2016-05-30 PHARMACEUTICAL COMBINATION OF ACECLOPHENAC AND SODIUM OR ANALYTING COMPONENT

Publications (1)

Publication Number Publication Date
UA113237U true UA113237U (en) 2017-01-25

Family

ID=58049688

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201605817U UA113237U (en) 2016-05-30 2016-05-30 PHARMACEUTICAL COMBINATION OF ACECLOPHENAC AND SODIUM OR ANALYTING COMPONENT

Country Status (1)

Country Link
UA (1) UA113237U (en)

Similar Documents

Publication Publication Date Title
DOP2017000137A (en) BENZAMIDES SUBSTITUTED WITH 1,3-THIAZOL-2-ILO.
DOP2016000156A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE AZD9291.
CO2019000945A2 (en) Modulators of the nmda spiro-lactam receptor and use thereof
CO2019000941A2 (en) Modulators of the nmda spiro-lactam receptor and use thereof
CO2019000943A2 (en) Modulators of the nmda spiro-lactam receptor and use thereof
AR096892A1 (en) A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MELANOMA
BR112015011430A2 (en) composition for immediate and prolonged release
EA201690679A1 (en) STABLE PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPIPIN AND VALSARTAN
MX2022001796A (en) Methods and compositions to inhibit symptoms associated with veisalgia.
CL2021002107A1 (en) Triamterene or nolatrexed for use in the treatment of phenylketonuria.
PH12018500817A1 (en) Pharmaceutical composition comprising metformin and lobeglitazone
UY37538A (en) AROMATIC AMIDES OF CARBOXYLIC ACIDS
EA201892842A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING SAFINAMID
ECSP16005208A (en) STABLE ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET INCLUDING ISONIAZID GRANULES AND RIFAPENTINE GRANULES AND THEIR PREPARATION PROCESS
BR112019017314A2 (en) pharmaceutical compositions for combination therapy
UA113237U (en) PHARMACEUTICAL COMBINATION OF ACECLOPHENAC AND SODIUM OR ANALYTING COMPONENT
BR112017014295A2 (en) pharmaceutical composition.
AR106415A1 (en) PHARMACEUTICAL COMPOSITION FOR PAIN TREATMENT
UA113233U (en) ORAL FIXED COMBINATION OF TENOXICAM AND THE SODIUM OR ANALYTING COMPONENT
WO2015166418A3 (en) Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient
CO2018013792A2 (en) Dosing regimens of vortioxetine for the rapid onset of the antidepressant effect
UA113236U (en) PHARMACEUTICAL FIXED COMBINATION WITH ANALYSIS AND SODIUM OR SOFTING EFFECTS BASED ON Meloxicam
AR099330A1 (en) USE OF PARICALCITOL IN THE TREATMENT OF INFLAMMATORY ANEMIA
NI201900084A (en) DROPROPIZIN IN COMBINATION WITH AMBROXOL IN THE PHARMACEUTICAL FORM OF SYRUP AND TABLETS
CR20150411A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DEXKETOPROPHENE AND TRAMADOL